Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

NCT07281716 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Microsatellite Stable Colorectal Carcinoma

Interventions

DRUG: Nadunolimab
DRUG: Toripalimab

Sponsor

Dan Feng

Collaborators

[object Object]
[object Object]